T. Haulk

发表

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

L. Grochow, K. Lillemoe, J. Cameron, 1999, International journal of radiation oncology, biology, physics.

Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.

S. Goodman, R. Abrams, D. Song, 2003, International journal of radiation oncology, biology, physics.

Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.

D. Ettinger, E. Fishman, S. Siegelman, 1987, International journal of radiation oncology, biology, physics.

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.

D. Ettinger, E. Fishman, E. Fishman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.

R. Abrams, R. Ambinder, R. Jones, 1997, Radiology.

Recurrent Prostate Cancer following Radiation Therapy Selective Oncolytic Adenovirus , for the Treatment of Locally A Phase I Trial of CV 706 , a Replication-competent , PSA Updated

S. Piantadosi, T. DeWeese, U. Hamper, 2001 .

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

H. G. van der Poel, Y. Chen, S. Piantadosi, 2001, Cancer research.

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.

D. Ettinger, S. Leibel, T. Pajak, 1991, International journal of radiation oncology, biology, physics.

Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.

D. Ettinger, E. Fishman, S. Order, 1991, International journal of radiation oncology, biology, physics.

Bacterial peritonitis following esophageal injection sclerotherapy for variceal hemorrhage.

P. Hoeprich, T. Prindiville, W. Trudeau, 1990, Gastrointestinal endoscopy.

Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients.

R. Abrams, H. Hurwitz, C. Enger, 1997, International journal of radiation oncology, biology, physics.

Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.

R. Abrams, T. Pajak, S. Asbell, 1998, The cancer journal from Scientific American.

Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.

R. Abrams, T. Pajak, B. Epstein, 1999, American journal of clinical oncology.